Phase 2 Hepatitis B Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who are willing to take part voluntarily and sign a consent form
- People aged 18 to 65 years old (including those who are exactly 18 or 65)
- People whose body weight relative to their height falls within the range required by the trial
- People who have had chronic hepatitis B (a long-term liver infection) with specific markers detectable in their blood for at least 6 months
- People whose previous medications meet the trial's specific requirements
- People whose hepatitis B blood markers and liver function test results fall within the levels required by the trial
- People who are using an effective method of contraception as specified by the trial
Who may not be able to join:
- People who have significant health conditions, other than chronic hepatitis B, that are not stable or well-controlled
- People who have other liver diseases in addition to hepatitis B
- People who have a serious infection (other than hepatitis B) that requires antibiotic or antiviral treatment given through a drip or IV
- People whose blood tests show positive results for hepatitis C, HIV, or syphilis
- People whose laboratory (blood or urine) test results fall outside the ranges acceptable to the trial
- People who have conditions involving inflammation of blood vessels
- People who have an abnormal heart rhythm reading on an ECG, specifically related to a measurement called the corrected QT interval (confirm with trial site)
- People who have had cancer in the past, or who are currently being assessed for a possible cancer diagnosis
- People who have a history of significant allergies or are considered to have a tendency toward allergic reactions
- People who have recently experienced a major injury or surgery, or who are planning to have surgery during the trial period
- People who are currently in another clinical trial, or who have not completed the required waiting period after a previous trial
- People who are currently taking, or have previously taken, medications that are not permitted under this trial's rules
- People considered unsuitable for the trial based on the overall judgment of the medical team running the trial
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Junqi Niu, The First Hospital of Jilin University
Phone: 0571-86959519
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Proportion of participants with persistent HBsAg < limit of detection (LOD) and HBV DNA < lower limit of quantification (LLOQ) at the 24th week after all treatment for CHB was discontinued.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.